Literature DB >> 19853833

Atypical and incomplete Kawasaki disease.

R Cimaz1, R Sundel.   

Abstract

Kawasaki disease (KD) is the most common systemic vasculitis in childhood after Henoch-Schonlein purpura, and the most common cause of acquired heart disease among children living in Western countries. Its diagnosis relies on clinical findings; laboratory tests are useful to rule out other causes of unexplained fever but are not specific for the diagnosis of KD. Numerous efforts to produce a diagnostic algorithm have been made, but without success. Expert opinion is therefore required in doubtful cases, especially those that lack classical criteria (the so-called atypical or incomplete cases). Renal, gastrointestinal, neurologic, pulmonary and ocular involvements have all been described. Infants may be at higher risk of complications since recognising manifestations of the disease might be more difficult in this group. Approaches to treatment and follow-up of KD are changing in parallel with changes in concepts of what constitutes classical and incomplete KD. Guiding this evolution is the probability that the diagnosis is actually KD, the duration of the child's illness and the desired effects of therapy. Until a gold standard for diagnosing KD is available, these therapeutic decisions will continue to be made on an individual basis.

Entities:  

Mesh:

Year:  2009        PMID: 19853833     DOI: 10.1016/j.berh.2009.08.010

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  19 in total

Review 1.  [Childhood vasculitis].

Authors:  J B Kümmerle-Deschner; J Thomas; S M Benseler
Journal:  Z Rheumatol       Date:  2015-12       Impact factor: 1.372

2.  Incomplete Kawasaki disease associated with complicated Streptococcus pyogenes pneumonia: A case report.

Authors:  Timothy Ronan Leahy; Eyal Cohen; Upton D Allen
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

3.  Shock: an unusual presentation of Kawasaki disease.

Authors:  Farah Thabet; Hend Bafaqih; Suleiman Al-Mohaimeed; Mariam Al-Hilali; Wafaa Al-Sewairi; May Chehab
Journal:  Eur J Pediatr       Date:  2011-02-24       Impact factor: 3.183

4.  Fever is not always present in Kawasaki disease.

Authors:  A L Rodriguez-Lozano; F E Rivas-Larrauri; V M Hernandez-Bautista; M A Yamazaki-Nakashimada
Journal:  Rheumatol Int       Date:  2011-09-01       Impact factor: 2.631

Review 5.  Describing Kawasaki shock syndrome: results from a retrospective study and literature review.

Authors:  Andrea Taddio; Eleonora Dei Rossi; Lorenzo Monasta; Serena Pastore; Alberto Tommasini; Loredana Lepore; Gabriele Bronzetti; Edoardo Marrani; Biancamaria D'Agata Mottolese; Gabriele Simonini; Rolando Cimaz; Alessandro Ventura
Journal:  Clin Rheumatol       Date:  2016-05-26       Impact factor: 2.980

6.  Spectrum of kawasaki disease.

Authors:  Megha Consul; Smita Mishra; Arvind Taneja
Journal:  Indian J Pediatr       Date:  2010-12-31       Impact factor: 1.967

7.  Bacillus Calmette-Guérin reactivation as a sign of incomplete Kawasaki disease.

Authors:  Cristina Novais; Fabiana Fortunato; Anabela Bicho; Luísa Preto
Journal:  BMJ Case Rep       Date:  2016-03-31

8.  Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.

Authors:  Mounika Reddy; Surjit Singh; Amit Rawat; Avinash Sharma; Deepti Suri; Manoj Kumar Rohit
Journal:  Rheumatol Int       Date:  2016-02-05       Impact factor: 2.631

9.  Erythema multiforme as first sign of incomplete Kawasaki disease.

Authors:  Francesco Vierucci; Cristina Tuoni; Francesca Moscuzza; Giuseppe Saggese; Rita Consolini
Journal:  Ital J Pediatr       Date:  2013-02-13       Impact factor: 2.638

10.  An unusual case of incomplete Kawasaki disease in an adolescent returning from holiday in Montana.

Authors:  Catherine Hyams; Thomas G Day; Shiva Ramroop; Stephanie Paget; Sasha Howard; Merlin McMillan; Surabhi Vora; Paul de Keyser
Journal:  Pediatr Cardiol       Date:  2012-03-08       Impact factor: 1.838

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.